http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MY-111022-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0009
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
filingDate 1994-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8c60d9f79120c19db9f24362b9a07d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e340fa49ff18d14d52c9ac6d05496600
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4b232fb1d694f2d272731936158d44e
publicationDate 1999-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MY-111022-A
titleOfInvention Iontophoretic delivery of an antimigraine drug.
abstract THE PRESENT INVENTION RELATES TO THE IONTOPHORETIC DELIVERY TO A PATIENT, MORE IN PARTICULAR TO A MIGRAINE PATIENT, OF A COMPOUND OF FORMULA ( I ) AS SHOWN HEREINUNDER.THE INVENTION ALSO RELATES TO A DEVICE FOR THE IONTOPHORETIC DELIVERY OF A COMPOUND OF FORMULA ( I ), AS WELL AS TO A COMPOSITION CONTAINING A COMPOUND OF FORMULA ( I ), WHICH CAN BE APPLIED IN A DEVICE FOR IONTOPHORETIC DELIVERY. SAID COMPOUNDS ARE BENZOPYRANALKYLAMINOALKYL SUBSTITUTED GUANIDINES HAVING THE FORMULA THE PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALTS THEREOF, AND STEREOCHEMICAL LY ISOMERIC FORMS THEREOF, WHEREIN R1 IS HYDROGEN OR C1 ? 6 ALKYL; R2 IS HYDROGEN, C1 - 6 ALKYL, C3 ? 6 ALKENYL OR C3 ? 6 ALKYNYL; R3 IS HYDROGEN OR C1 -6 ALKYL; OR R2 AND R3 TAKEN TOGETHER FORM A BIVALENT RADICAL OF FORMULA - ( CH2 ) M-WHEREIN M IS 4 OR 5 : OR R1 AND R2 TAKEN TOGETHER FORM A BIVALENT RADICAL OF FORMULA - CH = CH - OR OF FORMULA - ( CH2 )N-. WHEREIN N IS 2, 3 OR 4; OR R3 MAY REPRESENT A BOND WHEN R1 AND R2 TAKEN TOGETHER FORM A BIVALENT RADICAL OF FORMULA - CH = CH - CH =; R4 AND R5 EACH INDEPENDENTLY ARE HYDROGEN OR C1 ? 6 ALKYL; ALK1 IS A BIVALENT C1 ? 3 ALKANEDIYL RADICAL; ALK2 IS A BIVALENT C2-15 ALKANEDIYL RADICAL; AND R6 AND R7 EACH INDEPENDENTLY ARE HYDROGEN, HALO, C1 - 6 ALKYL, C3 -6 ALKENYL, C3 -6 ALKYNYL, HYDROXY, C1 ? 6 ALKYLOXY OR CYANO.
priorityDate 1993-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783

Total number of triples: 28.